Bruce Rogers - 09 Sep 2021 Form 4 Insider Report for Morphic Holding, Inc.

Role
Chief Scientific Officer
Signature
/s/ Robert Farrell as attorney-in-fact for Bruce Rogers
Issuer symbol
N/A
Transactions as of
09 Sep 2021
Net transactions value
-$2,307,245
Form type
4
Filing time
13 Sep 2021, 19:04:47 UTC
Next filing
21 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $129,600 +30,000 +33% $4.32* 119,905 09 Sep 2021 Direct F1
transaction MORF Common Stock Sale $102,039 -1,701 -1.4% $59.99 118,204 09 Sep 2021 Direct F2, F3
transaction MORF Common Stock Sale $1,352,136 -22,213 -19% $60.87 95,991 09 Sep 2021 Direct F2, F4
transaction MORF Common Stock Sale $374,918 -6,086 -6.3% $61.60 89,905 09 Sep 2021 Direct F2, F5
transaction MORF Common Stock Options Exercise $35,765 +8,279 +9.2% $4.32* 98,184 10 Sep 2021 Direct
transaction MORF Common Stock Sale $539,078 -8,279 -8.4% $65.11 89,905 10 Sep 2021 Direct F2, F6
transaction MORF Common Stock Options Exercise $7,435 +1,721 +1.9% $4.32* 91,626 13 Sep 2021 Direct
transaction MORF Common Stock Sale $111,873 -1,721 -1.9% $65.00 89,905 13 Sep 2021 Direct F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -30,000 -14% $0.000000 190,713 09 Sep 2021 Common Stock 30,000 $4.32 Direct F8
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -8,279 -4.3% $0.000000 182,434 10 Sep 2021 Common Stock 8,279 $4.32 Direct F8
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -1,721 -0.94% $0.000000 180,713 13 Sep 2021 Common Stock 1,721 $4.32 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 56 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.42 to $60.36 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.42 to $61.41 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.42 to $61.82 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.53 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The option vests as to 2.0833% of the total shares monthly, beginning January 14, 2019, with 100% of the total shares vested and exercisable on December 14, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.